Antibiotic consumption and resistance selection in Streptococcus pneumoniae

F Baquero1, G Baquero-Artigao, R Cantón

  • 1Department of Microbiology, Hospital Ramón y Cajal, Carretera de Colmenar Viejo, km 9.1, 28034 Madrid, Spain. fbaquero.hrc@salud.madrid.org

Insights

Antibiotic use drives the selection of resistant Streptococcus pneumoniae globally. Controlling

Area of Science:

  • Microbiology
  • Epidemiology
  • Public Health

Background:

  • Antibiotic resistance in Streptococcus pneumoniae is a significant global health concern.
  • Antibiotic consumption directly correlates with the selection and prevalence of resistant bacterial strains across all ecological levels.
  • Multiple drug resistance intensifies antibiotic selection pressure, with varying selective powers among different antibiotic classes.

Purpose of the Study:

  • To analyze the relationship between antibiotic consumption and the selection of antibiotic-resistant Streptococcus pneumoniae.
  • To investigate the asymmetrical co-selection phenomenon between macrolide and beta-lactam resistance.
  • To explore sociobiological determinants influencing antibiotic consumption and propose strategies for control.

Main Methods:

  • Review of ecological levels of antibiotic resistance correlation.
  • Analysis of asymmetrical co-selection dynamics for macrolide and beta-lactam resistance.
  • Identification of sociobiological factors influencing antibiotic consumption patterns.

Main Results:

  • Antibiotic use inevitably selects for resistant Streptococcus pneumoniae.
  • Macrolides exhibit a more efficient co-selection of resistance to both macrolides and beta-lactams compared to aminopenicillins.
  • Factors such as genetic predispositions, cultural attitudes, and public health issues influence antibiotic consumption.

Conclusions:

  • Antibiotic resistance is a direct consequence of antibiotic use, necessitating control over 'excess' consumption.
  • The concept of 'appropriate demand for antibiotics' (ADA) is proposed to manage antibiotic usage effectively.
  • Understanding the sociobiological determinants of antibiotic consumption is crucial for developing targeted interventions.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Antibiotic Selection01:45

Antibiotic Selection

Researchers use antibiotic resistance genes to identify bacteria that possess a plasmid containing their gene of interest. Antibiotic resistance naturally occurs when a spontaneous DNA mutation creates changes in bacterial genes that eliminate antibiotic activity. Bacteria can share these new resistance genes with their offspring and other bacteria. The overuse and misuse of antibiotics have created a public health crisis, as resistant and multi-resistant bacteria continue to develop.Antibiotic...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...